Literature DB >> 7752101

Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

P Wang1, G R Luthin, M R Ruggieri.   

Abstract

Activation of muscarinic acetylcholine receptors is primarily responsible for urinary bladder emptying. Because multiple subtypes of muscarinic receptors exist, we wished to characterize those present in bladder and ultimately to attribute function to those that regulate bladder contractility, neurotransmitter release and perhaps other cholinergic functions in this tissue. Although the m2 and m3 subtypes could be immunoprecipitated after solubilization from human, rat, rabbit and guinea pig bladder membranes, the m1, m4 and m5 subtypes could not. The m2:m3 ratio was 9:1 in rat bladder but was only 3:1 in the other species examined. Immunoprecipitation of the m2 subtype correlated with the relative levels of high-affinity agonist binding sites measured by competition of carbachol for [3H]N-methylscopolamine binding or measured directly using [3H]oxotremorine-M. In the presence of agonist, but not antagonist, GTP binding proteins could be immunoprecipitated in concert with the m2 or m3 receptors using anti-receptor antibodies. These proteins were members of the Gi and Gq/11 subfamilies for both the m2 and the m3 receptor subtypes. In spite of the preponderance of the m2 receptor in all species studied, Schild analysis using somewhat selective antagonists showed that the pharmacologically defined m3 receptor mediated contractility in strips of rat and rabbit bladder. Thus acetylcholine activates bladder smooth muscle via the m3 receptor subtype, and subsequent contractility may be transduced by guanine nucleotide binding proteins such as the Gi and Gq/11 subfamilies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752101      PMCID: PMC3277792     

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  26 in total

Review 1.  Muscarinic receptors--characterization, coupling and function.

Authors:  M P Caulfield
Journal:  Pharmacol Ther       Date:  1993-06       Impact factor: 12.310

2.  Heterogeneity of muscarinic receptors coupled to phosphoinositide breakdown in guinea pig brain and peripheral tissues.

Authors:  L Noronha-Blob; V C Lowe; R C Hanson; D C U'Prichard
Journal:  Life Sci       Date:  1987-08-24       Impact factor: 5.037

3.  Differences between binding affinities of some antimuscarinic drugs in the parotid gland and those in the urinary bladder and ileum.

Authors:  L Nilvebrant; B Sparf
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-10

4.  The guanine nucleotide activating site of the regulatory component of adenylate cyclase. Identification by ligand binding.

Authors:  J K Northup; M D Smigel; A G Gilman
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

5.  Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit.

Authors:  H Lepor; M J Kuhar
Journal:  J Urol       Date:  1984-08       Impact factor: 7.450

6.  Identification of a family of muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; N J Buckley; A C Young; M R Brann
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

7.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

8.  Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid gland.

Authors:  S Batra; A Biörklund; H Hedlund; K E Andersson; A Björklund
Journal:  J Auton Nerv Syst       Date:  1987-08

9.  Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.

Authors:  G D'Agostino; H Kilbinger; M C Chiari; E Grana
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

10.  A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.

Authors:  M Korc; M S Ackerman; W R Roeske
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

View more
  61 in total

1.  The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro.

Authors:  T Yamanishi; C R Chapple; K Yasuda; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Muscarinic receptors: what we know.

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

3.  M(3) muscarinic receptors mediate contraction of human urinary bladder.

Authors:  Charlotte Fetscher; Marina Fleichman; Martina Schmidt; Susanne Krege; Martin C Michel
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

4.  Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor.

Authors:  W Xu; S Gelber; A Orr-Urtreger; D Armstrong; R A Lewis; C N Ou; J Patrick; L Role; M De Biasi; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 5.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 6.  Improving the tolerability of anticholinergic agents in the treatment of overactive bladder.

Authors:  Roger Dmochowski
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Anti-muscarinic drugs increase rectal compliance and exacerbate constipation in chronic spinal cord injury : Anti-muscarinic drug effect on neurogenic bowel.

Authors:  Abhilash Paily; Guiseppe Preziosi; Prateesh Trivedi; Anton Emmanuel
Journal:  Spinal Cord       Date:  2019-02-25       Impact factor: 2.772

8.  Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.

Authors:  Tomomi Oki; Shuichi Sato; Keiji Miyata; Shizuo Yamada
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 9.  A benefit-risk assessment of extended-release oxybutynin.

Authors:  Martin C Michel
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder.

Authors:  A S Braverman; G R Luthin; M R Ruggieri
Journal:  Am J Physiol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.